KG.US Kestrel Group, Ltd.

Financial Services Pharmaceuticals USA Stocks
3.36 USD
Close of Nov 15, 2026
3.36 15.99
Market cap
USD 29.4M
P/E
-
P/B
0.30x
ROE
-43.4%
Dividend yield
136.25%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is KG.US undervalued?

Graham number

The Graham number of Kestrel Group, Ltd. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Kestrel Group, Ltd. fundamental analysis

No fundamental analysis for Kestrel Group, Ltd. yet.

Kestrel Group, Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Kestrel Group, Ltd.

Kestrel Group Ltd engages in the reinsurance business. It operates through two segments: Program Services and Legacy Reinsurance. The company offers fronting services to insurance program managers, managing general agencies, reinsurers, and reinsurance brokers in Bermuda. The company is based in Hamilton, Bermuda.

Full company profile